Discount-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
112 Ergebnisse
| DN2N67 | Gilead Sciences Inc./Discount/100/Call/DZ | - | - | Gilead Sciences Inc. | 26,508 % | 6,743 % | 6,743 % | - | 100,000 | 30.03.2027 | DZ Bank | ||
| DN3FVB | Gilead Sciences Inc./Discount/110/Call/DZ | - | - | Gilead Sciences Inc. | 25,621 % | 9,397 % | 9,397 % | - | 110,000 | 24.12.2027 | DZ Bank | ||
| DN3FVC | Gilead Sciences Inc./Discount/120/Call/DZ | - | - | Gilead Sciences Inc. | 21,294 % | 11,766 % | 11,766 % | - | 120,000 | 24.12.2027 | DZ Bank | ||
| DN3FVD | Gilead Sciences Inc./Discount/130/Call/DZ | - | - | Gilead Sciences Inc. | 17,369 % | 14,308 % | 14,308 % | - | 130,000 | 24.12.2027 | DZ Bank | ||
| DN3FVE | Gilead Sciences Inc./Discount/140/Call/DZ | - | - | Gilead Sciences Inc. | 13,902 % | 17,020 % | 11,215 % | - | 140,000 | 24.12.2027 | DZ Bank | ||
| DN3U0T | Gilead Sciences Inc./Discount/150/Call/DZ | - | - | Gilead Sciences Inc. | 10,904 % | 19,945 % | 8,544 % | - | 150,000 | 24.12.2027 | DZ Bank | ||
| DU13XS | Gilead Sciences Inc./Discount/100/Call/DZ | - | - | Gilead Sciences Inc. | 23,777 % | 4,223 % | 4,223 % | - | 100,000 | 25.09.2026 | DZ Bank | ||
| DU13XT | Gilead Sciences Inc./Discount/110/Call/DZ | - | - | Gilead Sciences Inc. | 16,566 % | 7,459 % | 7,459 % | - | 110,000 | 25.09.2026 | DZ Bank | ||
| DU13XU | Gilead Sciences Inc./Discount/120/Call/DZ | - | - | Gilead Sciences Inc. | 11,964 % | 13,725 % | 13,725 % | - | 120,000 | 25.09.2026 | DZ Bank | ||
| DU2CFW | Gilead Sciences Inc./Discount/130/Call/DZ | - | - | Gilead Sciences Inc. | 5,752 % | 35,945 % | 35,945 % | - | 130,000 | 25.09.2026 | DZ Bank | ||
| DU2CFX | Gilead Sciences Inc./Discount/130/Call/DZ | - | - | Gilead Sciences Inc. | 9,134 % | 23,802 % | 23,802 % | - | 130,000 | 28.12.2026 | DZ Bank | ||
| DU3TL5 | Gilead Sciences Inc./Discount/100/Call/DZ | - | - | Gilead Sciences Inc. | 27,840 % | 7,062 % | 7,062 % | - | 100,000 | 24.06.2027 | DZ Bank | ||
| DU3TL6 | Gilead Sciences Inc./Discount/110/Call/DZ | - | - | Gilead Sciences Inc. | 22,448 % | 9,794 % | 9,794 % | - | 110,000 | 24.06.2027 | DZ Bank | ||
| DU3TL7 | Gilead Sciences Inc./Discount/120/Call/DZ | - | - | Gilead Sciences Inc. | 17,837 % | 13,311 % | 13,311 % | - | 120,000 | 24.06.2027 | DZ Bank | ||
| DU3W40 | Gilead Sciences Inc./Discount/90/Call/DZ | - | - | Gilead Sciences Inc. | 34,254 % | 5,604 % | 5,604 % | - | 90,000 | 24.06.2027 | DZ Bank | ||
| DU4FRB | Gilead Sciences Inc./Discount/130/Call/DZ | - | - | Gilead Sciences Inc. | 13,821 % | 17,370 % | 17,370 % | - | 130,000 | 24.06.2027 | DZ Bank | ||
| DU5RFV | Gilead Sciences Inc./Discount/140/Call/DZ | - | - | Gilead Sciences Inc. | 2,572 % | 63,760 % | 16,332 % | - | 140,000 | 25.09.2026 | DZ Bank | ||
| DU7J3K | Gilead Sciences Inc./Discount/140/Call/DZ | - | - | Gilead Sciences Inc. | 5,926 % | 34,712 % | 15,328 % | - | 140,000 | 28.12.2026 | DZ Bank | ||
| DU7MDB | Gilead Sciences Inc./Discount/140/Call/DZ | - | - | Gilead Sciences Inc. | 11,313 % | 20,255 % | 14,024 % | - | 140,000 | 24.06.2027 | DZ Bank | ||
| DU7PY3 | Gilead Sciences Inc./Discount/150/Call/DZ | - | - | Gilead Sciences Inc. | 3,945 % | 48,362 % | 9,995 % | - | 150,000 | 28.12.2026 | DZ Bank | ||
| DU7QKT | Gilead Sciences Inc./Discount/150/Call/DZ | - | - | Gilead Sciences Inc. | 8,519 % | 25,132 % | 10,238 % | - | 150,000 | 24.06.2027 | DZ Bank | ||
| DU8L16 | Gilead Sciences Inc./Discount/130/Call/DZ | - | - | Gilead Sciences Inc. | 11,833 % | 19,971 % | 19,971 % | - | 130,000 | 30.03.2027 | DZ Bank | ||
| DU8L21 | Gilead Sciences Inc./Discount/140/Call/DZ | - | - | Gilead Sciences Inc. | 8,527 % | 26,362 % | 14,118 % | - | 140,000 | 30.03.2027 | DZ Bank | ||
| DU8L31 | Gilead Sciences Inc./Discount/150/Call/DZ | - | - | Gilead Sciences Inc. | 5,865 % | 33,803 % | 9,435 % | - | 150,000 | 30.03.2027 | DZ Bank | ||
| DU8QGL | Gilead Sciences Inc./Discount/120/Call/DZ | - | - | Gilead Sciences Inc. | 15,994 % | 14,507 % | 14,507 % | - | 120,000 | 30.03.2027 | DZ Bank | ||
| DU9PYV | Gilead Sciences Inc./Discount/110/Call/DZ | - | - | Gilead Sciences Inc. | 20,677 % | 9,709 % | 9,709 % | - | 110,000 | 30.03.2027 | DZ Bank | ||
| DY65AS | Gilead Sciences Inc./Discount/90/Call/DZ | - | - | Gilead Sciences Inc. | 32,314 % | 4,866 % | 4,866 % | - | 90,000 | 28.12.2026 | DZ Bank | ||
| DY65AT | Gilead Sciences Inc./Discount/100/Call/DZ | - | - | Gilead Sciences Inc. | 25,107 % | 5,983 % | 5,983 % | - | 100,000 | 28.12.2026 | DZ Bank | ||
| DY65AU | Gilead Sciences Inc./Discount/110/Call/DZ | - | - | Gilead Sciences Inc. | 18,790 % | 9,677 % | 9,677 % | - | 110,000 | 28.12.2026 | DZ Bank | ||
| DY68H3 | Gilead Sciences Inc./Discount/85/Call/DZ | - | - | Gilead Sciences Inc. | 35,851 % | 4,433 % | 4,433 % | - | 85,000 | 28.12.2026 | DZ Bank | ||
| DY8FB8 | Gilead Sciences Inc./Discount/80/Call/DZ | - | - | Gilead Sciences Inc. | 39,635 % | 4,151 % | 4,151 % | - | 80,000 | 28.12.2026 | DZ Bank | ||
| DY9PWJ | Gilead Sciences Inc./Discount/120/Call/DZ | - | - | Gilead Sciences Inc. | 13,431 % | 15,653 % | 15,653 % | - | 120,000 | 28.12.2026 | DZ Bank | ||
| MM0A31 | Gilead Sciences Inc./Discount/75/Call/MS | - | - | Gilead Sciences Inc. | 43,151 % | 3,003 % | 3,003 % | - | 75,000 | 28.12.2026 | Morgan Stanley | ||
| MM0A32 | Gilead Sciences Inc./Discount/100/Call/MS | - | - | Gilead Sciences Inc. | 25,245 % | 6,558 % | 6,558 % | - | 100,000 | 28.12.2026 | Morgan Stanley | ||
| MM0A33 | Gilead Sciences Inc./Discount/125/Call/MS | - | - | Gilead Sciences Inc. | 11,113 % | 19,248 % | 19,248 % | - | 125,000 | 28.12.2026 | Morgan Stanley | ||
| MM8338 | Gilead Sciences Inc./Discount/75/Call/MS | - | - | Gilead Sciences Inc. | 42,553 % | 1,117 % | 1,117 % | - | 75,000 | 25.09.2026 | Morgan Stanley | ||
| MM8339 | Gilead Sciences Inc./Discount/100/Call/MS | - | - | Gilead Sciences Inc. | 23,743 % | 3,679 % | 3,679 % | - | 100,000 | 25.09.2026 | Morgan Stanley | ||
| MM833A | Gilead Sciences Inc./Discount/125/Call/MS | - | - | Gilead Sciences Inc. | 7,661 % | 23,979 % | 23,979 % | - | 125,000 | 25.09.2026 | Morgan Stanley | ||
| MN0DTL | Gilead Sciences Inc./Discount/75/Call/MS | - | - | Gilead Sciences Inc. | 44,670 % | 4,471 % | 4,471 % | - | 75,000 | 24.06.2027 | Morgan Stanley | ||
| MN0DTM | Gilead Sciences Inc./Discount/100/Call/MS | - | - | Gilead Sciences Inc. | 28,506 % | 8,154 % | 8,154 % | - | 100,000 | 24.06.2027 | Morgan Stanley | ||
| MN0DTN | Gilead Sciences Inc./Discount/125/Call/MS | - | - | Gilead Sciences Inc. | 17,176 % | 14,329 % | 14,329 % | - | 125,000 | 24.06.2027 | Morgan Stanley | ||
| MN3ZWZ | Gilead Sciences Inc./Discount/150/Call/MS | - | - | Gilead Sciences Inc. | 1,181 % | 102,207 % | 7,391 % | - | 150,000 | 25.09.2026 | Morgan Stanley | ||
| MN3ZX1 | Gilead Sciences Inc./Discount/150/Call/MS | - | - | Gilead Sciences Inc. | 8,029 % | 27,733 % | 9,626 % | - | 150,000 | 24.06.2027 | Morgan Stanley | ||
| MN3ZX2 | Gilead Sciences Inc./Discount/150/Call/MS | - | - | Gilead Sciences Inc. | 3,679 % | 47,623 % | 9,294 % | - | 150,000 | 28.12.2026 | Morgan Stanley | ||
| MN702U | Gilead Sciences Inc./Discount/75/Call/MS | - | - | Gilead Sciences Inc. | 43,890 % | 3,948 % | 3,948 % | - | 75,000 | 30.03.2027 | Morgan Stanley | ||
| MN702V | Gilead Sciences Inc./Discount/100/Call/MS | - | - | Gilead Sciences Inc. | 26,982 % | 7,806 % | 7,806 % | - | 100,000 | 30.03.2027 | Morgan Stanley | ||
| MN702W | Gilead Sciences Inc./Discount/125/Call/MS | - | - | Gilead Sciences Inc. | 13,834 % | 17,243 % | 17,243 % | - | 125,000 | 30.03.2027 | Morgan Stanley | ||
| MN702X | Gilead Sciences Inc./Discount/150/Call/MS | - | - | Gilead Sciences Inc. | 6,126 % | 34,248 % | 9,884 % | - | 150,000 | 30.03.2027 | Morgan Stanley | ||
| MR3XE0 | Gilead Sciences Inc./Discount/75/Call/MS | - | - | Gilead Sciences Inc. | 46,228 % | 4,970 % | 4,970 % | - | 75,000 | 24.12.2027 | Morgan Stanley | ||
| MR3XE1 | Gilead Sciences Inc./Discount/100/Call/MS | - | - | Gilead Sciences Inc. | 31,284 % | 8,153 % | 8,153 % | - | 100,000 | 24.12.2027 | Morgan Stanley |